Arkolith/Insider Trading/FMDT/Form 4

Bizily Scott

Chief Legal and HR Officer4D Molecular Therapeutics, Inc. (FMDT) · full profile →Form 4 · filed Jun 12, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$78K
Net Open-Market Flow
-$78K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2023Sell(S)4K$20.85$78K2K
Jun 8, 2023Option exercise(M)4K$8.04$30K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 8, 2023Option exercise(M)4K—$049K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000153) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML